Viewing StudyNCT00110877



Ignite Creation Date: 2024-05-05 @ 11:42 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00110877
Status: COMPLETED
Last Update Posted: 2015-07-03
First Post: 2005-05-13

Brief Title: TMC114-C214 Trial of TMC114 Administered With Low Dose Ritonavir RTV in HIV-1 Infected Treatment Experienced Patients
Sponsor:
Organization: Tibotec Pharmaceuticals Ireland

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 604
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE3
Observational Models:
Time Perspective List:
Who Masked List: